Statistics

Total Visits

Views
Preliminary circulating tumour cell (CTC) analysis in phase II study of weekly cabazitaxel for "unfit" metastatic castration resistant prostate cancer patients (mCRPC) progressing after docetaxel treatment (SOGUG-CABASEM trial).77

Select a period of time:

Number of views in the range

Views
Preliminary circulating tumour cell (CTC) analysis in phase II study of weekly cabazitaxel for "unfit" metastatic castration resistant prostate cancer patients (mCRPC) progressing after docetaxel treatment (SOGUG-CABASEM trial).23

Views

Views
December 20251
January 20267
February 20261
March 20264
April 20267
May 20262
June 20261
Download CSV file
 untranslated
 untranslated

Top country views

Views
United States10
Morocco2
France2
Australia1
Chile1
Germany1
Algeria1
Ecuador1
Egypt1
Mexico1
 

Top cities views

Views
San Jose8
Agadir1
Casablanca1
Chihuahua City1
El Guabo1
Groningen1
Radès1
Santiago1
Seattle1
Tanta1